MicrobiologybioRxiv
Evaluation of SARS-CoV-2 Entry, Inflammation and New Therapeutics in Human Lung Tissue Cells
J. Grau-Exposito, D. Perea, M. Suppi…·M. J. Buzon
This paper develops a method using primary human lung tissue cells to study SARS-CoV-2 entry, inflammation, and therapeutics, identifying new drug candidates and showing interferons do not modulate ACE2 expression.
DOI 10.1371/journal.ppat.1010171